Colombe Rous

As seen in: Taylor & Francis Online

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Colombe

Contact Colombe, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.

Claim your profile

Articles

Improving ulcerative colitis prospects through fecal microbiota transfer: atypical donor microbiota can boost success rate

Jan 11, 2026 |

By Stanislas Mondot, Ruma Raghuvanshi, Julie Cadiou, Colombe Rous

| Taylor & Francis Online

ABSTRACT Fecal microbiota transfer (FMT) has been used with variable success in the experimental treatment of ulcerative colitis (UC), and efforts to improve its efficacy very much remain a matter of trial and error. We recently predicted that atypical donor microbiota could improve results.

Open in Who Shared

See all 1 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.

Claim your profile

Get in touch with Colombe

Contact Colombe, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

For PR Teams

Overview

Use Cases

Capabilities

Industries

Introducing Curation Engine

Resources

Library

Commmunity

Customers

Company

Colombe Rous

Get in touch with Colombe

Actions

Is this you?

Articles

Improving ulcerative colitis prospects through fecal microbiota transfer: atypical donor microbiota can boost success rate

Actions

Is this you?

Get in touch with Colombe